.Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC54_BrinzolamideCombinations.BrinzolamideCombinations .Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC54_BrinzolamideCombinations.BrinzolamideCombinations| name: | BrinzolamideCombinations |
| ATC code: | S01EC54 | route: | ocular |
| n-compartments | 1 |
Brinzolamide is a carbonic anhydrase inhibitor used primarily for the reduction of intraocular pressure in patients with ocular hypertension or open-angle glaucoma. In fixed combinations (such as with timolol), it offers enhanced efficacy for lowering eye pressure. It is approved and widely used in ophthalmology today.
Estimated pharmacokinetic parameters for typical adult patients; no specific published population PK modeling data for brinzolamide combinations (S01EC54) were identified.